Is Belphen the Next Blockbuster Diet Drug?
(MedPage Today) -- Even though there are scant data, obesity researchers and patients have already put a name to a potential new weight-loss craze: Belphen, a combination of lorcaserin (Belviq) and phentermine.
ConclusionsThe increased risk of GDM in women with srPCOS was mostly attributed to overweight or obesity. Importantly, normal weight women with srPCOS did not seem to be at increased risk for developing GDM. However, hyperandrogenemia was associated with GDM even after adjustment for BMI. These findings strengthen the importance of weight management in reproductive ‐age women and suggest a noteworthy role of hyperandrogenemia in the pathophysiology of GDM.
ConclusionCombined laparoscopic pouch resizing and distalization are safe and can lead to adequate weight loss. This technique allows the combination of an added restriction and malabsorption to the previous RYGB and could lead to an improved weight loss.
Regional efforts to control the spread of COVID-19 have so far proven successful. Image Credit: Pacific CommunityBy William W. EllisTORONTO, May 29 2020 (IPS) By now, the impact of COVID19 on our daily lives has been well documented, especially in advanced economies. Anxiety about the future continues to grow everywhere. Much of the corporate news coverage we consume has focused on the toll this pandemic will take on mainland countries. Often neglected, however, is the unique position Pacific Island States find themselves in. Globally, there are close to 6 million confirmed cases of COVID19. According to the Pacific Commu...
ConclusionsUnlike [18F]FDG, [18F]BODIPY 1 showed prominent accumulation in BAT under both inactive and stimulated status. [18F]BODIPY 1 may serve as a valuable BAT PET agent to possibly assess BAT mitochondria density, thus BAT thermogenic capacity after further evaluation.
Contrast-enhanced ultrasound scans revealed patterns in the lung not typically...Read more on AuntMinnie.comRelated Reading: Use CTA to evaluate obese COVID-19 patients for PE risk Ultrasound scoring aids COVID-19 decisions COVID-19 can be seen on CT scans outside the chest Brain images may show 'cytokine storm' from COVID-19 Lung ultrasound identifies patients with COVID-19
A 59-year-old woman with history of breast cancer and tuberculosis was referred to our hospital complaining of abdominal pain, distention and feeling feverish. A triphasic CT scan showed several cystic liver lesions, with a 110x72mm septate lesion in segments II-III with infiltrative morphology, as well as mediastinal and paraaortic lymph nodes(Image 1). A malignant etiology could not be ruled out.
CONCLUSIONS: Diagnostic CTPA with 17 ml contrast media is possible in non-obese patients using low kVp, high pitch and carefully designed contrast media administration. ADVANCES IN KNOWLEDGE: By combining several procedures in a CTPA protocol, the contrast media dose can be minimized. PMID: 32436788 [PubMed - as supplied by publisher]
CT angiography (CTA) is an effective way to evaluate the risk of pulmonary...Read more on AuntMinnie.comRelated Reading: 3 uses for cinematic rendering of brain CTA scans CTA lowers costs, improves outcomes for minor stroke Are clinicians overusing CTA for carotid stenosis? CCTA, functional tests stratify heart disease risk by age New method estimates postsurgical AAA rupture risk on CTA
CONCLUSION: prompt diagnosis and more aggressive thromboprophylaxis in patients with inherited or acquired risk factors may prevent the negative evolution towards bowel necrosis of SMVT. KEY WORDS: Colorectal surgery, Superior mesenteric vein thrombosis, Hypercoagulable disorders, Thromboprophylaxis. PMID: 32390649 [PubMed - in process]
Large nationwide observational study with national quality and research registry.